AT449619T
Medium and matrix for long-term proliferation of cells
Abstract
The present invention provides a method of stimulating vascularization at a site in a mammal, said method comprising contacting said site with a matrix comprising gelatin and a nitric oxide inhibitor. The gelatin is preferably denatured collagen. The nitric oxide inhibitor may be a sulfonated moiety. The inhibitor may be an L-arginine analog, such as aminoguanidine, N-monoethyl L-arginine, N-nitro-L-arginine and D-arginine. The matrix may further comprise a nitric oxide scavenger, such as dextran, heparin, cysteine and cystine.
Term
Term ended
Expired 9 July 2019, 7.2 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
84 members in 12 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 11343798 | United States of America | A | |
| 34621299 | United States of America | A | |
| 9915465 | United States of America | W |
Members84
| Document | Office | Kind | |
|---|---|---|---|
| CA2109065A1 | Canada | A1 | |
| WO9316685A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU3729693A | Australia | A | |
| NO933844D0 | Norway | D0 | |
| NO933844L | Norway | L | |
| EP0587840A1 | European Patent Office (EPO) | A1 | |
| JPH06509812A | Japan | A | |
| EP0587840A4 | European Patent Office (EPO) | A4 | |
| AU663938B2 | Australia | B2 | |
| US5614205A | United States of America | A | |
| CA2239498A1 | Canada | A1 | |
| WO9720569A2 | World Intellectual Property Organization (WIPO) | A2 | |
| ZA9610297B | South Africa | B | |
| AU1119297A | Australia | A | |
| WO9720569A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO9832841A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU6029298A | Australia | A | |
| EP0865288A2 | European Patent Office (EPO) | A2 | |
| US5824331A | United States of America | A | |
| US5830492A | United States of America | A | |
| US5834005A | United States of America | A | |
| US5908633A | United States of America | A | |
| EP0587840B1 | European Patent Office (EPO) | B1 | |
| AU714465B2 | Australia | B2 | |
| CA2332701A1 | Canada | A1 | |
| CA2337047A1 | Canada | A1 | |
| CA2337051A1 | Canada | A1 | |
| DE69327281D1 | Germany | D1 | |
| WO0002596A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO0002600A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO0002999A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU4977299A | Australia | A | |
| AU4977399A | Australia | A | |
| AU5095299A | Australia | A | |
| WO0002999A3 | World Intellectual Property Organization (WIPO) | A3 | |
| JP2000507202A | Japan | A | |
| DE69327281T2 | Germany | T2 | |
| NO309124B1 | Norway | B1 | |
| EP1094849A1 | European Patent Office (EPO) | A1 | |
| EP1096962A1 | European Patent Office (EPO) | A1 | |
| US6231881B1 | United States of America | B1 | |
| EP1098959A2 | European Patent Office (EPO) | A2 | |
| US2001007658A1 | United States of America | A1 | |
| US6261587B1 | United States of America | B1 | |
| US2001010826A1 | United States of America | A1 | |
| US2001019841A1 | United States of America | A1 | |
| US6315994B2 | United States of America | B2 | |
| US6352707B1 | United States of America | B1 | |
| JP3291297B2 | Japan | B2 | |
| JP2002520013A | Japan | A | |
| AU756049B2 | Australia | B2 | |
| AU757968B2 | Australia | B2 | |
| AU758833B2 | Australia | B2 | |
| EP1321516A2 | European Patent Office (EPO) | A2 | |
| EP1321516A3 | European Patent Office (EPO) | A3 | |
| FI111335B | Finland | B | |
| EP0865288B1 | European Patent Office (EPO) | B1 | |
| CA2239498C | Canada | C | |
| AT247478T | Austria | T | |
| ATE247478T1 | Austria | T1 | |
| DE69629583D1 | Germany | D1 | |
| CA2109065C | Canada | C | |
| US6713079B2 | United States of America | B2 | |
| US6730315B2 | United States of America | B2 | |
| DE69629583T2 | Germany | T2 | |
| JP3606585B2 | Japan | B2 | |
| EP1321516B1 | European Patent Office (EPO) | B1 | |
| AT321126T | Austria | T | |
| ATE321126T1 | Austria | T1 | |
| DE69635940D1 | Germany | D1 | |
| EP1094849B1 | European Patent Office (EPO) | B1 | |
| AT326243T | Austria | T | |
| ATE326243T1 | Austria | T1 | |
| DE69931371D1 | Germany | D1 | |
| DE69635940T2 | Germany | T2 | |
| CA2337047C | Canada | C | |
| CA2337051C | Canada | C | |
| DE69931371T2 | Germany | T2 | |
| EP1096962B1 | European Patent Office (EPO) | B1 | |
| AT449619TThis record | Austria | T | |
| ATE449619T1 | Austria | T1 | |
| DE69941707D1 | Germany | D1 | |
| CA2332701C | Canada | C | |
| ES2337320T3 | Spain | T3 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 99933792
Titles2
- German
- METHODE ZUR VERMINDERUNG DER IMMUNERKENNUNG
- English
- METHOD OF REDUCING IMMUNE DETECTION
Classification
- CPC, 26
- A61K9/0024
- A61F2/022
- A61K47/183
- A61K47/36
- A61K47/20
- A61K47/42
- A61K2035/122
- A61K2035/128
- A61L15/32
- A61L15/44
- A61L27/222
- A61L27/26
- A61L27/3683
- A61L27/38
- A61L27/52
- A61L27/54
- A61L2300/114
- A61L2300/204
- A61L2300/214
- A61L2300/236
- A61L2300/41
- A61L2300/434
- A61L2300/45
- A61L2300/62
- A61L2430/40
- A61P15/02
- IPC, 22
- A61L33 00
- C12Q1 02
- A61F2 02
- A61K9 00
- A61K31 721
- A61K35 12
- A61K38 39
- A61K47 18
- A61K47 36
- A61K47 42
- A61L15 32
- A61L15 44
- A61L27 22
- A61L27 26
- A61L27 38
- A61L27 52
- A61L27 54
- A61L31 00
- A61P15 02
- C12N5 02
- C12N5 07
- C12N5 071